Matthew Henry Hayn, MD in So. Portland, ME - Medicare Urology

Matthew Henry Hayn, MD is a medicare enrolled "Urology" physician in So. Portland, Maine. He went to University Of Pittsburgh School Of Medicine and graduated in 2003 and has 21 years of diverse experience with area of expertise as Urology. He is a member of the group practice Maine Medical Partners, Mainehealth and his current practice location is 100 Brickhill Ave, So. Portland, Maine. You can reach out to his office (for appointments etc.) via phone at (207) 773-1728.

Matthew Henry Hayn is licensed to practice in Maine (license number MD18757) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1891941779.

Contact Information

	Matthew Henry Hayn, MD
	100 Brickhill Ave, So. Portland, ME 04106
	(207) 773-1728
	(207) 772-4062

Physician's Profile

Full Name	Matthew Henry Hayn
Gender	Male
Speciality	Urology
Experience	21 Years
Location	100 Brickhill Ave, So. Portland, Maine
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Matthew Henry Hayn attended and graduated from University Of Pittsburgh School Of Medicine in 2003

NPI Data:

NPI Number: 1891941779
Provider Enumeration Date: 08/12/2008
Last Update Date: 04/18/2012

Medicare PECOS Information:

PECOS PAC ID: 6406993872
Enrollment ID: I20110811000252

Medical Identifiers

Medical identifiers for Matthew Henry Hayn such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1891941779	NPI	-	NPPES
03142014	Medicaid	NY

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	250440 (New York)	Secondary
208800000X	Urology	MD18757 (Maine)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Maine Medical Center	Portland, ME	Hospital
Maine General Medical Center	Augusta, ME	Hospital
Southern Maine Health Care	Biddeford, ME	Hospital
Mid Coast Hospital	Brunswick, ME	Hospital
Memorial Hospital, The	North conway, NH	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Maine Medical Partners	9335043967	789
Mainehealth	7517860588	2067

News Archive

New studies may offer hope for people with migraine

Two new studies may offer hope for people with migraine. The two studies released today will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.

Research shows use of ResMed's myAir results in better response to CPAP therapy in sleep apnoea patients

ResMed today announced new European research from Price Waterhouse Coopers (PwC), revealing patients with sleep apnoea who use ResMed's myAir have greater adherence to their CPAP therapy than patients not using myAir. myAir is ResMed's digital and online support programme that enables patients to track their own treatment and get personalised coaching tips to support motivation.

New drug shows promise to treat women with estrogen positive metastatic breast cancer

Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer in women with metastatic disease.

Community-based approaches to combat obesity

The EU faces alarming increases in obesity and associated health problems such as cardiovascular disease, cancer and diabetes.

Genentech terminates dacetuzumab collaboration agreement with Seattle Genetics

Seattle Genetics, Inc. today reported that it has been notified by Genentech, a wholly owned member of the Roche Group, that Genentech has elected to terminate the companies' collaboration agreement for dacetuzumab (SGN-40). Dacetuzumab is a monoclonal antibody targeting CD40 that has been investigated in clinical trials for non-Hodgkin lymphoma and multiple myeloma.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Matthew Henry Hayn allows following entities to bill medicare on his behalf.

Entity Name	Maine Medical Partners
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1598780447 PECOS PAC ID: 9335043967 Enrollment ID: O20040220000847

News Archive

New studies may offer hope for people with migraine

Research shows use of ResMed's myAir results in better response to CPAP therapy in sleep apnoea patients

New drug shows promise to treat women with estrogen positive metastatic breast cancer

Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer in women with metastatic disease.

Community-based approaches to combat obesity

The EU faces alarming increases in obesity and associated health problems such as cardiovascular disease, cancer and diabetes.

Genentech terminates dacetuzumab collaboration agreement with Seattle Genetics

Entity Name	Mainehealth
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166

New studies may offer hope for people with migraine

Research shows use of ResMed's myAir results in better response to CPAP therapy in sleep apnoea patients

New drug shows promise to treat women with estrogen positive metastatic breast cancer

Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer in women with metastatic disease.

Community-based approaches to combat obesity

The EU faces alarming increases in obesity and associated health problems such as cardiovascular disease, cancer and diabetes.

Genentech terminates dacetuzumab collaboration agreement with Seattle Genetics

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Matthew Henry Hayn is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Matthew Henry Hayn, MD 301c Us Route 1, Scarborough, ME 04074 Ph: (207) 396-8600	Matthew Henry Hayn, MD 100 Brickhill Ave, So. Portland, ME 04106 Ph: (207) 773-1728

News Archive

New studies may offer hope for people with migraine

Research shows use of ResMed's myAir results in better response to CPAP therapy in sleep apnoea patients

New drug shows promise to treat women with estrogen positive metastatic breast cancer

Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer in women with metastatic disease.

Community-based approaches to combat obesity

The EU faces alarming increases in obesity and associated health problems such as cardiovascular disease, cancer and diabetes.

Matthew Henry Hayn, MD - Medicare Urology in So. Portland, ME

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

New studies may offer hope for people with migraine

Research shows use of ResMed's myAir results in better response to CPAP therapy in sleep apnoea patients

New drug shows promise to treat women with estrogen positive metastatic breast cancer

Community-based approaches to combat obesity

Genentech terminates dacetuzumab collaboration agreement with Seattle Genetics

Medicare Reassignments

New studies may offer hope for people with migraine

Research shows use of ResMed's myAir results in better response to CPAP therapy in sleep apnoea patients

New drug shows promise to treat women with estrogen positive metastatic breast cancer

Community-based approaches to combat obesity

Genentech terminates dacetuzumab collaboration agreement with Seattle Genetics

New studies may offer hope for people with migraine

Research shows use of ResMed's myAir results in better response to CPAP therapy in sleep apnoea patients

New drug shows promise to treat women with estrogen positive metastatic breast cancer

Community-based approaches to combat obesity

Genentech terminates dacetuzumab collaboration agreement with Seattle Genetics

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

New studies may offer hope for people with migraine

Research shows use of ResMed's myAir results in better response to CPAP therapy in sleep apnoea patients

New drug shows promise to treat women with estrogen positive metastatic breast cancer

Community-based approaches to combat obesity

Genentech terminates dacetuzumab collaboration agreement with Seattle Genetics

Urology Doctors in So. Portland, ME